期刊文献+

应用2D-DIGE及MALDI-TOF-MS筛选胰腺癌血清标志物 被引量:2

Screening serum markers of pancreatic cancer by 2D differential gel electrophoresis and MALDI-TOF-MS
原文传递
导出
摘要 目的利用比较蛋白质组学的方法对胰腺癌患者血清和对照组血清例进行分析,寻找胰腺癌潜在的特异性候选标志物。方法采用双向差异凝胶电泳分离40例胰腺癌患者、10例慢性胰腺炎患者、10例良性肿瘤患者和40例健康体检者外周血清蛋白质,利用基质辅助激光解析电离飞行时间质谱技术对差异显著的蛋白进行鉴定。结果成功鉴定出2个胰腺癌差异表达蛋白:转甲状腺素蛋白和载脂蛋白E。该组蛋白在胰腺癌组中呈高表达,在正常对照组、慢性胰腺炎组和良性肿瘤组中呈低表达。结论双向差异凝胶电泳联合基质辅助激光解析电离飞行时间质谱技术筛选胰腺癌患者外周血清中的特异性生物标志物的方法具有较好的重复性和稳定性。检测鉴定的差异蛋白质载脂蛋白E、转甲状腺素蛋白可能是胰腺癌早期诊断潜在的血清特异性生物标志物。 Objective A comparative proteomic method was used to analyse serum proteins between pancreatic cancer patients and control group, and to find a new protential specific marker. Methods Comparative analysis on the pancreatic peripheral blood protein profiling from 40 pancreatic cancer patients, 10 chronic pancreatitis patients, 10 benign tumor patients and 40 cancer-free controls was carried out by 2D differential gel electrophoresis, and dif- ferentially expressed proteins were identified by matrix- assisted laser desorption/ionization time of flight mass spec- trometry. Results Two differentially expressed proteins: transthyretin and apolipoprotein E were identified. Those proteins were highly expressed in pancreatic carcinoma group compared with normal control group, chronic pancrea- tiffs group and benign tumor group. Conclusion 2D differential gel electrophoresis and matrix-assisted laser de- sorption/ionization time of flight mass spectrometry technology in screening specific serum biomarkers of pancreatic cancer has a well repeatability and stability. The identified protein transthyretin in this study may be as specific ser- um biomarkers of pancreatic carcinoma.
出处 《国际外科学杂志》 2012年第5期313-317,F0003,共6页 International Journal of Surgery
基金 2011年度安徽省科技攻关计划资助项目(NO.11010402172)
关键词 胰腺癌 蛋白质组学 双向差异凝胶电泳 基质辅助激光解析电离飞行时间质谱 标志物 Pancreatic carcinoma Proteomics 2D differential gel electrophoresis Matrix-assisted laser de-sorption/ionization time of flight mass spectrometry Markers
  • 相关文献

参考文献20

  • 1Ferlay J, Pro'kin DM, Sleliarova-Foucher E, et al. Estimates of cancer incidence and mortality in Europe in 2008 [ J]. Eur J Cancer. 2010, 46(4): 765-781.
  • 2Vincenl A, Herman J, Schuhck R, el al. Pancreatic cancer[ J ]. Lancel, 2011, 378(8791): 607-620.
  • 3Granl WB. A muhicountry ecological study of risk-modifying factorsfor prostate cancer: apolipoprotein E epsilon4 as a risk factor and ce- reals as a risk reduction factor[ J]. Anticancer Res, 2010, 30 ( 1 ) : 189-199.
  • 4Bhattacharjee PS, Huq TS, Mandal TK, et al. A novel peptide derived from human apolipoprotein E is an inhibitor of tumor [ J ]. PLoSone, 2011, 6(1): e15905.
  • 5Bonomini F, Filippini F, Hayek T, et al. Apalipoprotein E and its role in aging and survival francesca bonomini [ J ]. Exp Gerontol, 2010, 45(2) : 149-157,.
  • 6Trompet S, Jukema JW, Katan MB, et al. Apolipoprotein E geno- type, plasma cholesterol, and cancer: a mendelian randomization study[ J]. Am J Epideminol, 2009, 170( 11 ) : 1415-1421.
  • 7Beppu T, Gil-Bernabe P, Boveda-Ruiz D, et al. High incidence of tumors in diabetic thrombin activatable fibrinolysis inhibitor and apolipoprotein E double-deficient mice [J]. J Tromb Haemost, 2010, 8(11) : 2514-2522.
  • 8Porrata-Doria T, Matta JL, Acevedo SF. Apolipoprotein E allelic frequency altered in women with early-onset breast cancer [ J]. Breast Cancer, 2010, 24(4) : 43-48.
  • 9Grant WB. The roles of ultraviolet-B irradiance, vitamin D, apoli- poprotein Ee4, and diet in the risk of prostate cancer [ J ]. Cancer Causes Control, 2011, 22( 1 ) : 157-158.
  • 10Trost Z, Marc J, Sok M, et al. Increased apolipoprotein E gene ex- pression and protein concentration in lung cancer tissue do not con- tribute to the clinical assessment of non-small cell lung cancer pa- tients[J]. Arch Med Res, 2008, 39(7) : 663-667.

二级参考文献16

  • 1Guo X,Cui Z.Current diagnosis and treatment of pancreatic cancer in China[J].Pancreas,2005,31(1):13-22.
  • 2Hugli TE.Structure and function of the anaphylatoxin[J].Springer Semin Immunopathol,1984,7(3):193-219.
  • 3Scholz W,McclurgMR,Cardenas GJ,et al.C5a-mediated release of interleukin 26 by human monocytes[J].Clin Immunol Immunopathol,1990,57(2):297-307.
  • 4Habermann JK,Roblick UJ,Luke BT,et al.Increased serum levels of complement C3a anaphylatoxin indicate the presence of colorectal tumors[J].Gastroenterology,2006,131(4):1020-1029.
  • 5Huvila J,Brandt A,Rojas CR,et al.Gene expression profiling of endometrial adenocarcinomas reveals increased apolipoprotein E expression in poorly differentiated tumors[J].Int J Gynecol Cancer,2009,19(7):1226-1231.
  • 6Chen YC,Pohl G,Wang TL,et al.Apolipoprotein E is required for cell proliferation and survival in ovarian cancer[J].Cancer Res,2005,65(1):331-337.
  • 7Venanzoni MC,Giunta S,Muraro GB,et al.Apolipoprotein E expression in localized prostate cancers[J].Int J Oncol,2003,22(4):779-786.
  • 8Trost Z,Marc J,Sok M,et al.Increased apolipoprotein E gene expression and protein concentration in lung cancer tissue do not contribute to the clinical assessment of non-small cell lung cancer patients[J].Arch Med Res,2008,39(7):663-667.
  • 9Sakashita K,Tanaka F,Zhang X,et al.Clinical significance of ApoE expression in human gastric cancer[J].Oncol Rep,2008,20(6):1313-1319.
  • 10Mrkonjic M,Chappell E,Pethe VV,et al.Association of apolipoprotein E polymorphisms and dietary factors in colorectal cancer[J].Br J Cancer,2009,100(12):1966-1974.

共引文献1

同被引文献17

  • 1Chio LF, Oon CJ. Changes in serum alpha 1 antitrypsin, alpha1 acid glycoprotein and beta 2 glycoprotein I in patients with malignant hepatocellular carcinoma. Cancer, 1979,43 : 596-604.
  • 2Palmer PE, Wolfe HJ. Alpha-antitrypsin deposition in primary hepatic carcinomas. Arch Pathol Lab Med, 1976, 100:232-236.
  • 3Hsu PI, Chen CH, Hsieh CS, et al. Alphal-antitrypsin precursor in gastric juice is a novel biomarker for gastric cancer and ulcer. Clin Cancer Res, 2007,13:876-883.
  • 4Lopez-adrias E, Aguilar-Lemarroy A, Felipe Jave-Sudrez L, et al. Alpha 1-antitrypsin: a novel tumor-associated antigen identified in patients with early-stage breast cancer. Electrophoresis, 2012,33:2130-2137.
  • 5Xie LQ, Zhao C, Cai SJ, et al. Novel proteomic strategy reveal combined alphal antitrypsin and cathepsin D as biomarkers for colorectal cancer early screening. J Proteome Res, 2010,9:4701-4709.
  • 6Wang Y, Kuramitsu Y, Yoshino S, et al. Screening for serological biomarkers of pancreatic cancer by two dimensional electrophoresis and liquid chromatography- tandem mass spectrometry. Oncol Rep, 2011,26 : 287-292.
  • 7Primhak RA, Tanner MS. Alpha-1 antitrypsin deficiency. Arch Dis Child, 2001,85:2-5.
  • 8Chang YH, Lee SH, Liao IC, et al. Secretomic analysis identifies alpha-1 antitrypsin (A1AT) as a required protein in cancer cell migration, invasion, and pericellular fibronectin assembly for facilitating lung colonization of lung adenocarcinoma cells. Mol Cell Proteomics, 2012, 11: 1320-1339.
  • 9王靖雯,杨林青,刘涛,张玉英,高永花,李晓剑,刘飞飞.基质金属蛋白酶-9及血管内皮生长因子在卵巢癌中表达及其关系研究[J].中华实用诊断与治疗杂志,2010,24(7):661-663. 被引量:16
  • 10廖存,贺永明,吴留成,甘嘉亮,曹云飞,高枫.血清CEA阴性结直肠癌患者血清差异蛋白质的初步筛选[J].结直肠肛门外科,2011,17(3):131-136. 被引量:8

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部